Sorry, you need to enable JavaScript to visit this website.

So far – So good!

You appear to meet the basic requirements for this COVID-19 Vaccine study. Please enter your information below to find a study location near you. Once you select a site, the research study staff will contact you to see if you qualify to enroll.

So far – So good!

Your child appears to meet the basic requirements for this COVID-19 vaccine study. However, only the research study staff can fully determine if your child qualifies to enroll. Please enter your contact information and select “Find a Site” to see if there is a study site enrolling in your area.

Note: Parents and guardians should input their contact information, not their child’s.

Sorry, you are not eligible at this time...

Thank you so much for your interest in this COVID-19 vaccine study and for answering our questions. Contact your healthcare provider if you have any medical questions. Also, please consider entering your information below to be contacted about future clinical research opportunities.

Sorry, you are not eligible at this time...

Thank you for your interest in this COVID-19 vaccine study and for answering our questions. Contact your healthcare provider if you have any medical questions. Also, please consider entering your information below to be contacted about future clinical research opportunities.

Make a Difference in the Fight Against COVID-19

A new Pfizer & BioNTech COVID-19 vaccine study is underway for children and adults who are immunocompromised due to underlying conditions. Answer a few questions to see if you or your child may be able to participate.

Header

Question 1 of 3

Are you or your child (2 – 17 years old) immunocompromised due to an underlying medical condition or treatment for an underlying medical condition? See details about underlying medical conditions here

Question 2 of 3

Have you or your child been previously diagnosed with COVID-19?

Question 3 of 3

Have you or your child previously received a COVID-19 vaccine?

Please select a full valid address.

Choose a Location

Please select a research site near you. If you don’t see a site near you, then select "The sites listed here are not convenient for me." and a study representative will contact you if a site opens in your area.

The sites listed here are not convenient for me.

About the COVID-19 Vaccine Study for Immunocompromised Patients

Every modern vaccine and medicine we have today was first studied in clinical trials involving hundreds to thousands of people before becoming available to the public. Previous clinical trials involving this COVID-19 vaccine were not designed to include most patients with compromised immune systems. This trial will help determine how safe and tolerable the COVID-19 study vaccine is for individuals with compromised immune systems, and how well their immune systems respond to the vaccine.

By choosing to volunteer, you will represent people like you with conditions that make them immunocompromised.

Who Can Participate
 

  • Adults at least 18 years of age who have been diagnosed with one of the following:
    • Non-Small Cell Lung Cancer
    • Chronic Lymphocytic Leukemia
    • End-Stage Renal Disease on hemodialysis
    • Receiving immunomodulators therapy for an autoimmune inflammatory disorder
  • Children 2-17 years of age for which one of the following is true:
    • Receiving immunomodulators therapy for an autoimmune inflammatory disorder
    • Are receiving maintenance antirejection medications for an organ transplant
    • Have undergone a bone marrow or stem cell transplant
  • Participants should not have been previously diagnosed with COVID-19
  • Participants should not have already received a COVID-19 vaccine

Note: These are not the only eligibility criteria for this clinical research study. A clinical research team member will help determine if this study is right for your child based on all of the participation criteria.

Header Image

What to Expect

icon

All participants will receive the COVID-19 study vaccine. You or your child will receive 3 doses over the course of 6-7 months. Doses will be given as an injection in the upper arm. The first 2 injections will be given about 3 weeks apart at the start of study. A third injection will be given at a later date.

icon

All participants will have at least 7 scheduled visits at the study site and will be a part of the study for about 14 months.

icon

All participants will be asked to track any symptoms or side effects in an electronic diary (e-diary).

icon

All participants will be paid a stipend per visit to serve as reimbursement for their expenses (such as parking, meals, travel) and time related to completing the e-diary.

Header Image
Pfizer Logo
BioNTech Logo